WeChat Mini Program
Old Version Features

Tocilizumab Versus Baricitinib in Hospitalized Patients with Severe COVID-19: an Open Label, Randomized Controlled Trial

Theodoros Karampitsakos,Ourania Papaioannou,Panagiota Tsiri,Matthaios Katsaras,Andreas Katsimpris,Andreas P. Kalogeropoulos,Elli Malakounidou,Eirini Zarkadi,Georgios Tsirikos,Vasiliki Georgiopoulou,Vasilina Sotiropoulou,Electra Koulousousa,Charikleia Chourpiliadi,Apostolos Matsioulas,Maria Lagadinou,Fotios Sampsonas,Karolina Akinosoglou,Markos Marangos,Argyris Tzouvelekis

CLINICAL MICROBIOLOGY AND INFECTION（2023）

Cited 30|Views41
Key words
Baricitinib COVID-19,Mortality,PaO2,FiO2,Tocilizumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined